MedPath

Ery-Ped

ERY-PED (ERYTHROMYCIN ETHYLSUCCINATE, USP)

Approved
Approval ID

04775721-ab87-4b66-808c-d67a21032385

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 16, 2023

Manufacturers
FDA

Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)

DUNS: 117505635

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Erythromycin Ethylsuccinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code24338-130
Application NumberNDA050207
Product Classification
M
Marketing Category
C73594
G
Generic Name
Erythromycin Ethylsuccinate
Product Specifications
Route of AdministrationORAL
Effective DateDecember 16, 2023
FDA Product Classification

INGREDIENTS (6)

CARAMELInactive
Code: T9D99G2B1R
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
ERYTHROMYCIN ETHYLSUCCINATEActive
Quantity: 400 mg in 5 mL
Code: 1014KSJ86F
Classification: ACTIM
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT

Erythromycin Ethylsuccinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code24338-132
Application NumberNDA050207
Product Classification
M
Marketing Category
C73594
G
Generic Name
Erythromycin Ethylsuccinate
Product Specifications
Route of AdministrationORAL
Effective DateDecember 16, 2023
FDA Product Classification

INGREDIENTS (6)

POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
CARAMELInactive
Code: T9D99G2B1R
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
ERYTHROMYCIN ETHYLSUCCINATEActive
Quantity: 200 mg in 5 mL
Code: 1014KSJ86F
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ery-Ped - FDA Drug Approval Details